Policy → market
Market alerts
Not financial advice
Commercial cliffs from presidential documents — role pressure, mechanisms, and a curated issuer watchlist. Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.
How this works
- Cliff vs glide — dates that change market access differ from multi-year programs.
- Role pressure — protective / adverse / mixed for supply-chain roles (not a stock tip).
- Named issuers — curated watchlist only.
- Price window — optional EOD chart around issue and cliff dates; coincidence, not causation.
- in 40dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
Tariffs effective for other companies
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - in 884dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
Zero tariff rate expires for companies with MFN pricing agreements
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - in 1321dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
20% onshoring rate increases to 100%
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - Issued Feb 26, 2025
Defending American Companies and Innovators From Overseas Extortion and Unfair Fines and Penalties
This memorandum directs multiple agencies to investigate and counter foreign tax and regulatory practices—particularly d
EADSYAirbusAAAlcoaGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBABoeingBGBungeCATCaterpillar